These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12823400)

  • 1. An endoscopic injection device: a potential advance in the transurethral treatment of benign prostatic obstruction.
    Ditrolio J; Patel P; Watson RA; Irwin RI
    BJU Int; 2003 Jul; 92(1):143-5. PubMed ID: 12823400
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemo-ablation of the prostate with dehydrated alcohol for the treatment of prostatic obstruction.
    Ditrolio J; Patel P; Watson RA; Irwin RJ
    J Urol; 2002 May; 167(5):2100-3; discussion 2103-4. PubMed ID: 11956449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E
    J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.
    Wein AJ
    J Urol; 2005 Nov; 174(5):1903. PubMed ID: 16217335
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of transurethral ethanol ablation of prostate for symptomatic benign prostatic hyperplasia.
    Faruque MS; Alam MK; Ullah MA; Rahman MH; Kibria MG; Haque MM; Haque MA; Joarder AI; Paul BK
    Mymensingh Med J; 2012 Apr; 21(2):265-9. PubMed ID: 22561769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraprostatic ethanol chemoablation via transurethral and transperineal injection.
    Plante MK; Gross AL; Kliment J; Kida M; Zvara P
    BJU Int; 2003 Jan; 91(1):94-8. PubMed ID: 12614259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol injection for the treatment of benign prostatic hyperplasia.
    Kim ED
    Curr Urol Rep; 2002 Aug; 3(4):276-9. PubMed ID: 12149157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of transperineal injection of dehydrated ethanol in the treatment of prostatic obstruction.
    Chiang Po; Chuang YC; Huang CC; Chiang CP
    Urology; 2003 Apr; 61(4):797-801. PubMed ID: 12670568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.
    Kuo HC
    Urology; 2005 Apr; 65(4):670-4. PubMed ID: 15833506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic tissue ablation by injection: a literature review.
    Plante MK; Folsom JB; Zvara P
    J Urol; 2004 Jul; 172(1):20-6. PubMed ID: 15201730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
    Gerstenberg T; Blaabjerg J; Nielsen ML; Clausen S
    Invest Urol; 1980 Jul; 18(1):29-31. PubMed ID: 6157651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silodosin (Rapaflo) for benign prostatic hyperplasia.
    Med Lett Drugs Ther; 2009 Jan; 51(1303):3-4. PubMed ID: 19122568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydroxyprogesterone caproate on experimental benign prostatic obstruction in the mouse.
    Caine M; Superstine E
    Isr J Med Sci; 1973; 9(11):1559-64. PubMed ID: 4130461
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of benign enlargement of the prostate with nor progesterone caproate (primostat).
    Subbiah N; Mortensen J
    Aust N Z J Surg; 1973 Feb; 42(3):304-7. PubMed ID: 4129814
    [No Abstract]   [Full Text] [Related]  

  • 15. Most bothersome symptom and symptom specific goal achievement in patients with benign prostatic obstruction: a prospective open label study.
    Lee YS; Lee HN; Han JY; Choo MS; Lee KS
    J Urol; 2011 Mar; 185(3):1003-9. PubMed ID: 21251673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous ethanol injection of the prostate as minimally invasive treatment for benign prostatic hyperplasia: preliminary report.
    Savoca G; De Stefani S; Gattuccio I; Paolinelli D; Stacul F; Belgrano E
    Eur Urol; 2001 Nov; 40(5):504-8. PubMed ID: 11752856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical calculus secondary to ethanol gel injection into the prostate.
    Ikari O; Leitão VA; D'ancona CA; Matheus WE; Rodrigues Netto N
    Urology; 2005 May; 65(5):1002. PubMed ID: 15882750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intraprostatic injection of 96% ethanol in experimental animal model].
    Martov AG; Pavlov DA; Kirpatovskiĭ VI; Kudriavtsev IuV
    Urologiia; 2004; (6):21-6. PubMed ID: 15719725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.